Diethyl N-(tert-Butoxycarbonyl)phosphoramidate, 95%, 100mg

2-(4-Amino-2-chlorophenyl)-2,3-dihydro-1h-isoindole-1,3-dione, 97%, 1g

tert-Butyl octahydro-5H-pyrrolo[3,4-c]pyridine-5-carboxylate oxalate, 95%, 1g

(4R,5R)-5-((R)-1,2-Dihydroxyethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde, 95.0%, 25g

4-(2-Hydroxyethyl)-5-methyl-1H-pyrazol-3(2H)-one, 95.0%, 5g

Methyl 4-(2-aminoethoxy)benzoate, 95+%, 5g

2,4-Dichloro-5-methylthieno[2,3-d]pyrimidine, 97.0%, 10g

1-{4H,5H,6H,7H-pyrazolo[1,5-a]pyridin-3-yl}methanamine dihydrochloride, 95.0%, 500mg

6-(Dimethylamino)pyrazine-2-carboxylic acid, 95.0%, 500mg

Methyl 5-acetylthiophene-2-carboxylate, 98%, 1g

3-Chloro-6-pyridin-4-ylpyridazine, 97%, 1g

Fmoc-Ala-Cl, 95.0%, 10g

Boîtes de Petri divisées en 3 compartiments 10 pièces